U.S. flag

An official website of the United States government

Filters

Test type

Test purpose

Test method

Test service

Laboratory certification

Specimen type

See more specimen types...

Laboratory location

See more states

Other countries

Results: 1 to 20 of 106

Tests names and labsConditionsGenes, analytes, and microbesMethods

NGS Oncology Melanoma Profile (Tissue Only)

Diagnostic Laboratory Services, Inc.
United States
141
  • C Sequence analysis of the entire coding region

Guardant360 TissueNext

Guardant Health
United States
185
  • M Methylation analysis
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Guardant360 Response

Guardant Health
United States
174
  • E Sequence analysis of select exons
  • T Targeted variant analysis

NeXT Dx

Personalis, Inc.
United States
1413
  • I Microsatellite instability testing (MSI)
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Guardant360

Guardant Health
United States
184
  • I Microsatellite instability testing (MSI)
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Tempus xT

Tempus AI - RTP
United States
2647
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

NGS Oncology Tumor Profile

Diagnostic Laboratory Services, Inc.
United States
540
  • C Sequence analysis of the entire coding region

Tempus xT

Tempus AI - CHI
United States
2647
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

FoundationOne® Heme

Foundation Medicine, Inc.
United States
2405
  • D Deletion/duplication analysis
  • R RNA analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Tempus xF

Tempus AI - RTP
United States
1105
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

NEXT GEN SEQUENCING COMPREHENSIVE SOLID TUMOR PANEL

Alverno Laboratories
United States
127
  • T Targeted variant analysis

MayoComplete Lung Cancer Panel

Mayo Clinic Laboratories Mayo Clinic
United States
115
  • R RNA analysis
  • C Sequence analysis of the entire coding region

OnkoSight Advanced Bladder Cancer Panel

BioReference Health
United States
139
  • C Sequence analysis of the entire coding region

OnkoSight Advanced Breast Cancer Panel

BioReference Health
United States
150
  • C Sequence analysis of the entire coding region

Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR

PathGroup
United States
16160
  • T Targeted variant analysis

Precise Tumor Molecular Profile Testing

Myriad Genetics, Inc.
United States
146
  • I Immunohistochemistry
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

Cancer Hotspot Panel

Genome-Nilou Lab
Iran
4534
  • E Sequence analysis of select exons

Solid Tumor Fusion Analysis

Institute for Genomic Medicine (IGM) Clinical Laboratory Nationwide Children's Hospital
United States
1115
  • R RNA analysis

MayoComplete Solid Tumor Panel

Mayo Clinic Laboratories Mayo Clinic
United States
1476
  • I Microsatellite instability testing (MSI)
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 106

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.